Pantheon Resources PLC has named David Wilkins as its new CEO, effective immediately. Wilkins, an industry veteran with over 40 years of experience in Alaska's energy sector, joined the board in March and replaces Max Easley, who is moving to a senior role at a large Alaskan operator. Easley will stay on temporarily to ensure a smooth transition. Wilkins' extensive background includes senior roles at Hilcorp Alaska, Marathon Oil, and Dowell Schlumberger, positioning him well to lead Pantheon’s Kodiak and Ahpun projects and ongoing farm-out discussions.
Pantheon Resources' new CEO appointment provides context for energy sector activity on Pluang. For readers following energy stocks, here is Pluang's market snapshot as of Oct 01, 2026 12:31 WIB: Out of 38 priced energy-sector US stocks, 17 rose and 15 fell today. Suncor Energy Inc. (SU) traded at USD 65.29 with a 3.29% decline and 100% buy order activity, contrasting with Centrus Energy Corp (LEU) at USD 141.70 gaining 2.55% with 80% buy orders, while Solaredge Technologies Inc (SEDG) rose 2.03% to USD 32.16 despite 91% sell orders. Typical hold times ranged from 30 to 56 days among these assets.
Quant (QNT) token price increased to $300, up 5.16% over 24 hours, with a notable 4.09% rise within one hour on October 1. This price movement was recorded on Binance's spot QNT/USDT market. During the same hour, liquidations of short positions reach...
Primary Health Properties PLC has finalized financial terms and due diligence for its joint venture deals, aiming to use asset sale proceeds to reduce debt. The company targets lowering its net debt to EBITDA ratio below 9.5 and loan-to-value ratio u...
Rothe Development has filed for an IPO to raise working capital, partly to repay the CEO's personally guaranteed acquisition note. Despite a $635 million government contract backlog through 2025, the company shows uneven revenue growth, very low prof...
Defence Therapeutics announced its participation in the 17th World ADC San Diego conference, where CEO Dr. Amie Phinney will discuss advancements in intracellular delivery for antibody-drug conjugates (ADCs). The company will showcase its proprietary...
Standard Chartered initiated coverage on Ethena, assigning a $2 price target for its ENA token by the end of 2028, implying a potential 669% increase from current levels near $0.26. The bank projects the USDe stablecoin supply to grow from $4.9 billi...
